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Primary ductal adenocarcinoma of the lacrimal gland (PDALG) is a rare tumor accounting for less than 2% of all 
tumors arising within the orbit. It is classified as a high-grade malignant epithelial tumor due to its variable biologic 
behavior and aggressive clinical course. Due to its rare incidence, the clinicopathologic profile is poorly identified 
and generally dependent on the few available reports and case series. Metastatic lesion of PDALG presenting as a 
skin lesion is very rare with only one previously reported case. We report here a case of metastatic PDALG that 
presented with cutaneous features. This case illustrates that such a rare malignant tumor may present to derma-
tologists, requiring prompt diagnosis and management with a multidisciplinary approach. (Korean J Dermatol 2016; 
54(3):206∼209)
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INTRODUCTION
Primary ductal adenocarcinoma of the lacrimal gland 
(PDALG) is a rare, high-grade epithelial malignant tumor 
with variable clinical presentations and biologic behaviors. It 
accounts for less than 2% of all malignant tumors arising in 
the orbit1. Due to its rare incidence, the clinicopathologic 
profile is poorly defined are there are few case reports or 
case series available.
PDALG occurs as a rapidly growing palpable mass, 
usually exceeding the limits of adequate surgical excision at 
the time of presentation2. Histopathologic examination of the 
primary tumor shows pleomorphic cells with numerous mito-
tic figures arranged in cords along with lumen formation3,4.
Cutaneous metastasis of a lacrimal gland epithelial tumor 
is very rare with only a single case previously reported. 
Metastatic skin lesions of an adenocarcinoma usually occur 
as nonspecific firm nodules, mimicking other common dis-
orders5. Therefore, immunohistochemical study is necessary 
to determine the primary sites of metastatic lesions. The aim 
of this case report is to raise dermatologist awareness that 
rare malignant tumors may present with cutaneous features. 
CASE REPORT
A 51-year-old Korean male patient was referred to the 
dermatology department with a solitary plaque located on 
the cheek. The size and erythema of the lesion had been 
increasing over the previous four months, however, there 
were no other associated symptoms. 
Two years prior, the patient had been diagnosed with 
colorectal adenocarcinoma on routine health examination 
and an endoscopic mucosal resection was performed. No 
lymphovascular invasion was noted and colonoscopic evalua-
tion showed no recurrence or remnant lesions. After 6 
months, the patient presented to the ophthalmology depart-
ment with an indurated mass on his left eyelid. The mass 
had been present for 1 month and swelling of the eyelid 
and pain gradually intensified. A computed tomography (CT) 
scan showed a mass involving the left orbital cavity and the 
ethmoidal and frontal sinuses with enlarged lymph nodes. 
An excisional biopsy was performed on the medial orbital 
wall and found infiltration of clustered, atypical cells. These 
cells had prominent nucleoli with fine and granular cyto-
plasm filled with mucin. Neoplastic cells were positive for 
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Fig. 2. (A) Abnormal aggregates of glandular structure in epidermis and lower dermis with infiltrative growth (H&E, ×40). (B) 
Well-formed glandular and ductal structures composed of malignant epithelial cells with prominent nuclei (H&E, ×200). (C) The 
neoplastic cells showed positive for CK7 and negative for CK20 or CDX-2 (CK7, ×100).
Fig. 1. Photograph, magnetic re-
sonance (MRI) and positron emis-
sion tomography-computed tomo-
graphy (PET-CT) scan of the pa-
tient. (A) Solitary coin sized ery-
thematous to purple plaque on Lt. 
cheek. (B) MRI scan demonstrating
local recurrence on the left medial
orbital wall. (C) PET-CT scan re-
vealed newly developed numerous 
osteolytic lesions.
pan-keratin markers (CK AE1/3) and CEA but were 
negative for CD68, suggesting primary ductal adenocarci-
noma of the lacrimal gland (PDALG). Magnetic resonance 
imaging (MRI) and [18F]Fluorodeoxyglucose positron emis-
sion tomography-computed tomography (PET-CT) revealed 
hypermetabolic uptake in the surrounding sphenoid sinus 
and level I, II, and III lymph nodes; indicating regional 
infiltration. Due to the extent of the infiltration, left orbital 
exenteration and postoperative radiotherapy was recom-
mended. However, the patient insisted on globe-sparing 
treatment despite the consequent poor prognosis and under-
went concurrent chemoradiotherapy in place of the opera-
tion. The patient received a total of 10 cycles of weekly 
fluorouracil and cisplatin-based chemotherapy with tomo-
therapy (69.96 Gy) for the gross tumor and surrounding 
lymph nodes for a period of 2 months. The treatment was 
well-tolerated with no significant adverse reactions, aside 
from mild general weakness. Follow up imaging studies after 
3 and 6 months showed that the main mass had significantly 
decreased in size as well as a positive number of lymph 
nodes, indicating near-total or total response to therapy. 
However, 5 months after treatment, the patient returned 
to the clinic with complaints of upper eyelid induration and 
edema with an accompanying skin lesion on the ipsilateral 
cheek (Fig. 1A). A physical examination revealed a coin- 
sized erythematous plaque with induration. There was no 
palpable cervical lymphadenopathy. A skin biopsy revealed 
abnormal aggregates of the glandular structure in the epi-
dermis and lower dermis with an infiltrative pattern (Fig. 
2A). On high power view, well-formed glandular and ductal 
structures showed malignant epithelial cells with prominent 
nuclei (Fig. 2B). Immunohistochemical staining was performed 
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to exclude the possibility of metastatic colon adenocar-
cinoma. Neoplastic cells stained positive for CK7 and 
negative for CK20 and CDX-2, suggesting a metastatic 
lesion originating from a ductal adenocarcinoma of the 
lacrimal gland (Fig. 2C). An MRI scan revealed recurrence 
of the primary orbital tumor on the left medial orbital wall. 
Subsequent imaging study for the purposes of systemic 
evaluation revealed numerous newly- developed osteolytic 
lesions in the axial skeleton and proximal appendicular bones 
(Fig. 1B, C). The patient was treated again with a regimen 
of etoposide and cisplatin. He concomitantly received 
radiotherapy under a palliative setting and is under close 
observation. 
DISCUSSION
Space occupying lacrimal gland lesions are generally in-
flammatory and lymphocytic, while epithelial tumors account 
for just 20 to 30% of all cases. Primary epithelial tumors 
arising in the orbit include benign mixed tumors or pleo-
morphic adenoma, adenoid cystic carcinoma, and adenocarci-
noma; and the latter is the rarest subtype with an aggressive 
behavior6. PDALG was first documented by Katz et al.7 in 
1996 and since then, there have been few reported cases. 
There is a slight male predominance with a tendency to 
occur in the older population, however, its clinicopathologic 
profile is still poorly understood. The tumor often manifests 
as a rapidly-growing mass causing a wide range of visual 
symptoms including diplopia, ptosis, globe displacement, and 
visual loss. The clinical course shows early infiltration to the 
surrounding nasal cavity, paranasal sinuses, and other soft 
tissue structures8. Due to its aggressive nature, the recom-
mended treatment for PDALG involves exenteration or en 
bloc resection of the tumor mass with regional lymph node 
dissection, followed by radiation therapy as soon as histo-
logical confirmation is achieved. 
Cutaneous metastasis has not yet been reported in Korean 
patients with PDALG. Metastatic lesions most commonly 
involve the lungs and other internal organs. There has been 
one previous report of cutaneous metastasis of PDALG pre-
senting as an erythematous patch on the chest9. In patients 
with adenocarcinoma of the internal organs, cutaneous meta-
stasis develops in 0.7∼10% of cases, with varying incidence 
depending on the primary tumor subtype10. The prevalence 
of cutaneous metastasis of the visceral tumor amounts to 2% 
of all skin tumors. This usually presents as solitary, discrete, 
painless, and freely-movable plaques or nodules with sudden 
onset, preferentially occurring on surfaces located close to 
the site of the primary tumor. The most frequent primary 
origins in order of frequency are: the lungs, the colon and 
rectum, the breast, and the kidneys11. As an adenocarcinoma 
is the basic malignant neoplasm which can arise from all 
glandular structures, diagnosis is almost entirely dependent 
on histopathologic features, and immunohistochemical eval-
uation is mandatory for accurate assignment. 
As our patient had a history of colorectal adenocar-
cinoma; immunohistochemistry was performed for CK7, 
CK20, and CDX-2; with positive staining obtained for CK7. 
Metastatic adenocarcinoma of colorectal origin is known to 
express CDX-2 and stain negative for CK7 with very high 
sensitivity and specificity12-14. Based on the patient’s clinical 
course and immunohistochemical profile, the possibility of 
metastatic adenocarcinoma originating from the colon was 
excluded. 
Given the infrequent incidence of malignant lacrimal gland 
tumors, their immunohistochemical features are yet to be 
elucidated. Of the lacrimal gland epithelial tumors, PDALG 
shows more prominent mucin content during specimen exa-
mination, which can be demonstrated with mucicarmine and 
alcian blue stains. There exists a similarity between salivary 
and lacrimal gland tumors, with similar classification ac-
cording to histologic features. Both tumors show pleo-
morphic cells with many mitotic figures arranged in sheets 
and cords with variable amounts of mucin production15. 
Immunohistochemical studies of salivary duct carcinomas 
have shown that approximately 93% of tumors express 
androgen receptors, while expression of estrogen and proge-
sterone receptors is rare. A recent case series of five 
patients reviewed the clinicopathologic profiles and found 
that PDALG was positive for androgen receptors in all 
cases, with negative expression for estrogen and proges-
terone16. Thus, further understanding of the histopatholo-
gical and immunohistochemical characteristics may help to 
define this tumor’s pathogenesis and lead to successful treat-
ment outcomes. 
In summary, our case illustrates the first Korean case of 
an orbital adenocarcinoma presenting as a metastatic skin 
lesion, after showing a significant clinical response to con-
current chemoradiotherapy. Metastatic spread to the skin is 
rare and may suggest widespread metastatic disease, resulting 
in a poor prognosis. Immunohistochemical findings are essen-
tial to the diagnosis and further understanding of its path-
ogenesis can be postulated with supporting characteristic bio-
markers.
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